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Abstract: 
Aims: To assess the outcome of management of post-operative endophthalmitis with 
intravitreal injections of Vancomycin and Amikacin; both by measuring the visual acuity 
and assessing the corneal transparency. The study also aimed at identifying the causative 
organism, by culture and sensitivity and Gimsa staining of the vitreal tap. Materials and 
methods: This study was conducted in Makkah eye complex, Khartoum – Sudan, over a 
period from April 2003 till December 2004. Patients reported at out patient 
department(OPD) with signs and symptoms of endophthalmitis within six weeks after 
cataract surgery, they were examined initially for the visual acuity; then diffuse 
illumination and bio-microscopy examination was performed for grading clarity of 
cornea, and for checking presence of hypopyon or sufficient clouding of the anterior 
chamber, also intraocular inflammation was measured by the assessment of flare, cells, 
and inflammation membrane. Indirect ophthalmoscopy was performed to examine the red 
fundal glow and the status of the vitreous and retina. Inside the operating room vitreous 
and aqueous tap were done for the culture and sensitivity. Then the patients were treated 
with intravitreal and subconjuctival injection of Amikacin and Vancomycin. Results: In a 
total of (25) patients, pain and blurring of vision were found to be the most common 
symptoms, Insufficient corneal clarity 23 (92%) of patients, hypopyon was found at 
different levels in all patients, Red reflex was absent in 21 (84%) of patients. All the 
patients were found to have either vitritis, choroiditis or both in A and B scan. Post 
treatment findings of the 19 (76%) patients who attended the final six-month follow-up 
were as follow: The pain was relieved in all patients. The visual acuity had improved to a 
maximum of 6/18 one (5%) patient, 2 (10.5%) patients went into phthisis bulbi. The 
clarity of cornea was observed in 17 (89.5%) patients. Hypopyon disappeared from 17 
(89.5%) of patients after injection. Fundal glow reappeared in 12 (63%) of patients. The 
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results of remaining 6 (24%) patients who attended less than three-month follow-up 
period were as follow: Pain was relieved in (5) 83% of patients. The visual acuity reached 
a maximum of 3/60 in (1) 16.7% of patients, (1) 16.7% of the patients went into phthisis 
bulbi. The clarity of cornea was observed in (5) 83% of patients. (3)50% of patients were 
having no hypopyon after injection, fundal glow remains absent. Cultures were negative 
in (15) 60% of cases. (10) 40% showed confirmed growth of different organisms. 
Staphylococcus aureus (1) 4%, S. viridance (1) 4%, S. epidermidis (2) 8%, S. pyogenes 
(3) 12% and S. albus (3) 12%. 
Key words: bacterial endophthalmitis, intravitreal Amikacin and Vancomycin, 
vitreal tap 
Introduction: 
Post-operative endophthalmitis is a serious intra-ocular infection that occurs most 
commonly as a complication of intra-ocular surgery and causes severe visual 
impairment or the loss of an eye(1,2) As cataract extraction is the most common 
intra-ocular operation, most cases of endophthalmitis follow cataract surgery. 
Although the reported rate of post-operative endophthalmitis is low, the 
prevalence of endophthalmitis has increased significantly with the increasing 
number of cataract procedures performed. During the last 30 years there have 
been significant changes in surgical practices for cataract extraction. Intracapsular 
extraction was the main method used until the late 1970s; extracapsular extraction 
became the preferred method in the early 1980s due to the introduction of 
intraocular lens implantation; and improved instrumentation has led to the 
predominant use of small incision phacoemulsification since the late 1980s. The 
current state of the art is sutureless phacoemulsification surgery with injected 
foldable intra-ocular lenses, although some have described a fall in the incidence 
rate of post-operative endophthalmitis following extracapsular cataract surgery (3, 
4).While concerns about an increased risk of endophthalmitis with phaco-
emulsification surgery were raised, they have yet to be convincingly demonstrated 
(5) as phaco-emulsification surgery is almost universally performed today. The 
lack of information regarding the risk of post-surgical endophthalmitis is a 
significant gap in our knowledge of the safety of this new method of surgery. 
Most existing analyses of post- operative endophthalmitis have utilized data 
derived from individual centers or groups of surgeons which resulted in very low 
case numbers, making comparisons and statistical validity of data difficult. (3-4)The 
rarity of the disease means that a randomized control trial is not the appropriate 
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methodology to study this adverse outcome.Certain risk factors for the 
development of postoperative endophthalmitis have been suggested. These 
include cases complicated by inadvertent communication with the vitreous cavity, 
wound complications such as leaks, as well as surgeries that required prolonged 
operating time and excessive introduction and reintroduction of instruments into 
the anterior chamber6. The use of intraocular lenses with prolenehaptics appears to 
increase the chance of endophthalmitis when compared to the haptics made of 
polymethylmethacrylate (PMMA) (7). 
Past five decades have rendered cataract a treatable condition in many cases. Post 
cataract cases are restored to 20/40 acuity or better in approximately 50% of cases 
in the most favorable subgroups (least virulent organisms, good initial visual 
acuity, acute onset) but the remainders suffer permanent visual loss to varying 
degrees. Furthermore, certain sub groups (eg. Streptococcus) have been extremely 
difficult to treat, apparently due to the inability to control severe post infection 
inflammation within the eye. Practical strategies involving the use of diagnostic 
cultures, intravitreal and systemic antibiotic and anti-inflammatory drugs and 
vitrectomy are presented for both initial management as well as subsequent 
management of cases that deteriorates(8). 
Literature review: 
Endophthalmitis refers to an infection in which all the coats of the eye are 
involved. The infectious process, depending on the underlying cause, may present 
in different manners. If the infectious nidus is internal and has spread from 
another infected organ, it is called endogenous. If the infectious process follows 
intraocular surgery or penetrating ocular trauma, it is called exogenous. Both 
forms of endophthalmitis are true ophthalmic emergencies that can lead to 
blindness if not diagnosed and treated appropriately and aggressively (9). 
Infectious endophthalmitis is classified by the events leading to the infection and 
by the timing of the clinical diagnosis (10, 11). The broad categories include 
postoperative endophthalmitis (acute, delayed-onset, conjunctival filtering bleb 
associated), post-traumatic endophthalmitis, and endogenous endophthalmitis. 
These categories are important in predicting the causative organisms and guiding 
therapeutic decisions before microbiologic confirmation of the clinical diagnosis. 
Bacterial endophthalmitis occurs in a number of clinical settings. Compilation of 
large reported series suggests the following distribution of cases: 62 percent occur 
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following intraocular surgery, 20 percent occur following penetrating trauma, 10 
percent occur following planned or inadvertent filtering blebs and 8 percent occur 
as a result of metastatic infection (12, 13, and 14). 
The accurate diagnosis of endophthalmitis after cataract surgery requires attention 
to clinical symptoms and signs, as well as appropriately selected laboratory tests. 
The earliest symptom of endophthalmitis is usually discomfort or deep pain, 
although the rapid postoperative improvement in visual acuity with intra ocular 
lens(IOL) implantation has increased the number of patients reporting a loss of 
vision as the initial symptom of endophthalmitis. Signs of endophthalmitis include 
conjunctival hyperemia, chemosis, cells and flare in the anterior chamber, 
hypopyon, membrane formation on the IOL, vitritis, scattered retinal 
hemorrhages, loss of red reflex, and in extreme cases, corneal opacification. 
Retinal periphlebitis may be observed as an early sign of bacterial endophthalmitis 
(15). 
Approximately 64 percent of eyes with a clinical diagnosis of infectious 
endophthalmitis will have a positive culture result (16, 17).  
A major turning point in the development of successful therapy for 
endophthalmitis occurred in 1944 when Von Sallmann and colleagues 
demonstrated that the intraocular injection of penicillin eradicated S. aureus 
endophthalmitis in the rabbit. Intravitreal antibiotic therapy was subsequently 
developed further and has dramatically improved the possibility of salvaging 
vision in endophthalmitis (18). Of all available antimicrobial agents evaluated for 
intraocular injection, only a few are used regularly in clinical practice. Intraocular 
vancomycin (1 mg) in combination with an aminoglycoside (amikacin, 0.4 mg, or 
gentamicin, 0.1 mg) has been a commonly used regimen for the initial empiric 
treatment of presumed bacterial endophthalmitis (19, 20). An alternative to the 
aminoglycosides for coverage of gram-negative organism is the use of intraocular 
ceftazidime (2.25 mg), a third-generation cephalosporin (21, 22). Vancomycin has 
replaced cefazolin (a first-generation cephalosporin) for gram-positive bacterial 
coverage in recent years because of an increased incidence of coagulase-negative 
staphylococci resistance to methicillin or other β-lactam antibiotics (23, 24). 
Repeated injections of intraocular antibiotics may cause significant retinal 
toxicity. In view of the low rate of persistent infection after initial combination 
therapy, repeat injection of intraocular antibiotics should be considered only in 
those cases with progressive disease caused by virulent organism (25).   
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Justification: 
Postoperative endophthalmitis results from an intraocular infection and usually 
occurs following cataract surgery. Outcome for the patients can be devastating. 
Therefore, there is much interest in minimizing the occurrence of endophthalmitis. 
Modern management, which has included the use of intravitreal antibiotics, has 
changed the picture. The current treatment approaches can yield excellent visual 
results in postoperative endophthalmitis. 
The purpose of study is to give the outcome of timely management. 
Objectives: 
1. To assess the outcome of management of postoperative endophthalmitis with 
intravitrealVancomycin and Amikacin by measuring visual acuity and 
assessing corneal transparency. 
2. To identify the causative organism, by culture and sensitivity and Gimsa 
staining using vitreal tap. 
3. To establish base line data for further study in the same subject. 
 
Materials and Methods: 
Study area: 
This study was conducted in Makkah eye complex. Khartoum, Sudan. It is one of 
the biggest ophthalmic centers in Sudan. The study was carried out during period 
of April 2003 till December 2004. 
Study Population: 
Patients reported to out-patient department (OPD) of Makkah Eye Complex with 
signs and symptoms of endophthalmitis within six weeks after cataract surgery 
from different centers of Sudan. 
Methodology: 
A questionnaire was designed and completed for each patient. It consisted of: 
Bio data, present complaints, history of present complaints, past ocular history, 
Medical history. 
Examination: Visual acuity, Diffuse Illumination, Bio microscopy, 
Ophthalmoscopy (Direct/ Indirect), Schiotz tonometer. Investigations: A and B 
SCAN (pre and post treatment), Culture and sensitivity. Smear of aqueous and 
vitreous for microscopic examination 
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Study design:  
Prospective Study, patients who were eligible for study were examined; only 
those fulfilling the inclusive criteria, out of the total patients attending out- patient 
department in Makkah Eye Complex. Bio data which included name, age, and sex 
were filled in questionnaire. 
In the initial examination, vision was tested for the ability to see the Snelen's E 
chart, if failed then vision was tested for the ability to count fingers, if failed then 
tested for the ability to recognize hand motions and perception of light. During 
visual acuity testing the normal eye of the patient was occluded. Diffuse 
illumination: In addition to examination of ocular adnexa patients were also 
examined for the sufficient clarity of cornea and anterior chamber to allow the 
visualization of at least part of iris, and presence of hypopyon or sufficient 
clouding of the anterior chamber. Biomicroscopy: Patients were examined for 
cornea to assess corneal edema, and visualization of iris to assess the clarity of 
cornea. Intraocular inflammation was measured by the assessment of flare, cells, 
and inflammatory membranes. Size of the hypopyon in mm, inflammation of iris, 
wound leak, necrotic wound margins, suture abscess were also assessed. 
Ophthalmoscopy (Indirect): Indirect ophthalmoscopy was performed to see the 
red fundal glow and the status of the vitreous and retina. Visual acuity and clarity 
of ocular media are the two most important clinical criteria used for the 
assessment of treatment outcome. After examination patients were sent to the 
operation theatre where vitreous and aqueous tap were done for the culture and 
sensitivity. The samples were cultured in blood agar or in chocolate agar at the 
same time taps were collected on a glass slide for staining and were sent to the 
laboratory for results. After collection of the sample patients were treated with 
intravitreal and subconjunctival injection of amikacin and vancomycin. 
Procedure: Tools: 
Lid retractor, Caliber, 1 cc syringes: 05Qty, 5 cc syringes:  02Qty, 10 cc syringes: 
02 Qty, Two headed sterile swab: 02 Qty. 
The patient was given retrobulbar and facial anesthesia preoperatively. Lid 
retractor was used to separate the lid and to increase palpebral fissure working 
area. The caliber was used to determine the working distance from the limbus (3.5 
mm diagonally). A 25 gauge needle was used for the vitreous tap and 1cc syringe 
needle was used to aspirate the aqueous sample and both intravitreal and 
subconjunctival delivery of antibiotics used. 
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Amikacin was prepared by using 0.1 ml from vial and adding to it 6.15 ml of 
normal saline so as to get 0.1 ml (which contains 0.4 mg) for intravitreal injection. 
The subconjunctival volume was 0.1 ml (which contains 25mg) taken directly 
from the vial and injected. 
Vancomycin was prepared first by diluting a 500 mg vial powder with 10ml 
distilled water then taken from this initial diluents 0.2 ml and adding to it 0.8 ml 
normal saline to get 0.1 ml (which contain 1 mg) for intravitreal injection. Make 
partial – thickness sclerotomy 3.5 – 4.0 mm behind limbus. The subconjunctival 
was 0.5 ml (which contains 25 mg) taken direct from the initial diluents and 
injected.  
Samples for culture (Aqueous and Vitreous) were put in the blood or chocolate 
agar and with a zigzag movement were spread with a sterile swab. The Petri 
dishes were rapped with sticker to avoid contamination. The slide sample 
(Aqueous and Vitreous) was left on the glass slide to dry in room temperature. 
Patients were given a date for follow – up next day. During this period results 
were collected from the laboratory. After one- week patients were examined and 
assessed for the clarity of cornea (on defined rules) and visual acuity. A and B 
scan was also done and compared with pre – treatment. Treatment was modified 
according to the results of culture and sensitivity. 
Data analysis: 
Data was filled in SPSS (Statistical Package for Social Sciences) program and was 
analyzed and compared. 
Limitation of the Study: Some patients were not attending the follow up on 
given dates. 
Results: 
A total of 25 patients: (14) 56% were males, (11) 44% were females included in 
the study, out of these (19) 76% attended the six months final follow-up, while (6) 
24% attended less than three months follow-up. All the patients presented with 
clinical signs of bacterial endophthalmitis within six weeks of cataract surgery. 
The most common symptoms (Table 1)were pain and blurring of vision, visual 
acuity ranging from 3/60 down till NPL. Insufficient corneal clarity (23) 92% of 
patients, hypopyon was found at different levels in all patients, Red reflex was 
absent in (21) 84% of patients. All the patients were found to have vitritis, 
choroiditis or both in A and B scan. 
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Table (1): Follow-up-6 months-symptoms.(n=19)  
SYMPTOMS 
AFTER 
ENDOPHTHALMITIS 
AFTER 
INJECTION 
Frequency Percent Frequency Percent 
Pain 
Yes 19 100.0 1 5.2 
No - - 18 94.7 
Redness 
Yes 19 100.0 1 5.2 
No 0 0 18 94.7 
Lid swelling 
Yes 19 100.0 2 10.5 
No 0 0 17 89.5 
conjunctival 
chemosis 
Yes 19 100.0 2 10.5 
No 0 0 17 89.5 
Flare 
Unknown 0 0 2 10.5 
Yes 19 100.0 0 0 
No 0 0 17 89.5 
 
Table (2): Follow-up-6 months-signs.(n=19) 
SIGNS 
AFTER 
ENDOPHTHALMITIS 
AFTER 
INJECTION 
Frequency Percent Frequency Percent 
cells 
Unknown - - 2 10.5 
Yes 19 100.0 0 0 
No - - 17 89.5 
iritis 
Clear 1 5.2 16 84.2 
Muddy 18 94.7 1 5.2 
Cannot be 
recorded 
- - 2 10.5 
pupillary 
membrane 
Yes 7 36.8 3 15.8 
No 12 63.2 14 73.7 
Not-recorded - - 2 10.5 
Gezira Journal of Health Sciences June 2017 Volume 13(1)________________ 
Gezira Journal of Health Sciences June 2017 Volume 13(1)  9 
 
 
Post treatment findings of the (19) 76% patients who attended the final six-month 
follow-up were as follows(Table2): 
The pain was relieved in all patients. The visual acuity had improved to a 
maximum of 6/18 (1) 5% patient, (2) 10.5% patients went into phthisis bulbi. The 
clarity of cornea was observed in (17) 89.5% patients. 
Hypopyon disappeared from (17) 89.5% of patients after injection. Fundal glow 
reappeared in (12) 63% of patients (Table 3). 
The results of remaining (6) 24% patients who attended less than three-month 
follow-up period were as follow: Pain was relieved in (5) 83% of patients. The 
visual acuity reached a maximum of 3/60 in (1) 16.7% of patients, (1) 16.7% of 
the patients went into phthisis bulbi (Table 4). The clarity of corneal was observed 
in (5) 83% of patients. (3) 50% of patients were having no hypopyon after 
injection, fundal glow remains absent (Table 5). 
Cultures were negative in (15) 60% of cases. (10) 40% showed confirmed growth 
of different organisms. Staphylococcus aureus (1) 4%, S. viridance (1) 4%, S. 
epidermidis (2) 8%, S. pyogenes (3) 12% and S. albus (3) 12%. 
Table (3): Follow-up-6 months-investigation results.(n=19)  
  INVESTIGATION 
AFTER 
ENDOPHTHALMITIS 
AFTER 
INJECTION 
Frequency Percent Frequency Percent 
fundal glow 
Yes 4 21.0 12 63.2 
No 15 78.9 5 26.3 
Not recorded 
- - 2 10.5 
intraocular 
pressure 
High 6 31.6 0 0 
Normal 13 68.4 16 84.2 
Low 0 0 1 5.2 
Not-recorded 
(Soft) 
0 0 2 10.5 
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Table (4): Follow-up-3 months-symptoms and signs.(n=19) 
SYMPTOMS AND SIGNS 
AFTER 
ENDOPHTHALMITIS 
AFTER 
INJECTION 
Frequency Percent Frequency Percent 
pain Yes 6 100.0 1 16.7 
redness Yes 6 100.0 2 33.3 
lid swelling Yes 6 100.0 1 16.7 
conjunctival 
chemosis 
Yes 
6 100.0 2 33.3 
flare 
Unknown 0 0 1 16.7 
Yes 6 100.0 1 16.7 
No 0 0 4 66.7 
cells 
Unknown 0 0 1 16.7 
Yes 6 100.0 1 16.7 
No 0 0 4 66.7 
iritis 
Muddy 6 100.0 5 83.3 
Cannot be 
recorded 
- - 1 16.7 
 
Table (5): Follow-up-3- investigation results.(n=19) 
INVESTIGATION RESULTS 
AFTER 
ENDOPHTHALMITIS 
AFTER 
INJECTION 
Frequency Percent Frequency Percent 
fundal glow 
No 6 100.0 5 83.3 
Not recorded 0 0 1 16.7 
pupillary 
membrane 
Yes 5 83.3 3 50.0 
No 1 16.7 2 33.3 
Not recorded 0 0 1 16.7 
intraocular  
pressure 
Normal 1 16.7 3 50.0 
High 5 83.3 2 33.3 
Can not 
Be recorded 
- - 1 16.7 
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Figure (1) and (2): for the 19 patients 
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Figure (3) and (4): for the 6 patients 
 
Conclusions: 
Endophthalmitis after cataract extraction with severe visual loss have no too 
distant past. Modern management with the use of antibiotics like povine iodine 
5% preoperatively and an intravitreal antibiotics postoperatively, has changed the 
picture. Preoperatively assessments are very important to prevent the 
endophthalmitis. Abnormalities and infections of adnexis, conjunctiva and cornea 
should be treated preoperatively. It has been observed that the patient’s hygienic 
conditions are often the source of the organism causing infections. 
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Constant attention to postoperative complains of patients is critical, since early 
diagnosis allows early intervention and better outcomes. 
The mainstay of management is immediate introduction of intravitreal drugs that 
cover both gram positive and gram negative organism. Although the most 
common organisms that cause endophthalmitis are gram positive, at presentation 
it is very difficult to confirm the organism type, so intravitreal antibiotics to cover 
both organisms are used.Intravitreal antibiotics were given to all patients of the 
study, and those included either patients from perception of light (PL) or more 
hand motion (HM),counting fingers (CF) or more.In all patients an improvement 
in pain, the signs of inflammation and general condition of the patient was 
observed. Hand motion visual acuity patients got advantage that most of them had 
an improvement in their visual acuity sometimes up to 6/18. In perception of light 
visual acuity patients, though the visual improvement was not remarkable, they 
end up saving their globe (in the term of pthisisbulbi) resulting in a lesser 
psychological trauma than being eviscerated. 
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